Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 767 articles:
HTML format
Text format



Single Articles


    November 2016
  1. AMEN DG, Darmal B, Raji CA, Bao W, et al
    Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  2. BEHESHTI I, Maikusa N, Matsuda H, Demirel H, et al
    Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  3. ABU RUMEILEH S, Lattanzio F, Stanzani Maserati M, Rizzi R, et al
    Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Abeta42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  4. CAGNIN A, Fragiacomo F, Camporese G, Turco M, et al
    Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  5. QUARMLEY M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, et al
    Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  6. BERGERON D, Vermette A, De La Sablonniere J, Cayer AM, et al
    Finger-to-Nose Test Findings in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  7. MULLER S, Preische O, Heymann P, Elbing U, et al
    Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  8. SZABLEWSKI L
    Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  9. CARMONA-IRAGUI M, Santos T, Videla S, Fernandez S, et al
    Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  10. ALVES SARNO T, Leme Talib L, Passarelli Giroud Joaquim H, Farid Gattaz W, et al
    Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  11. ARROYO-ANLLO EM, Boustonb AT, Fargeau MN, Orgaz Baz B, et al
    Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  12. MOSS DE, Perez RG, Kobayashi H
    Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  13. GAMIR-MORRALLA A, Belbin O, Fortea J, Alcolea D, et al
    Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  14. MONACELLI F, Cea M, Borghi R, Odetti P, et al
    Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  15. REITER K, Nielson KA, Durgerian S, Woodard JL, et al
    Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  16. CHAU SA, Herrmann N, Sherman C, Chung J, et al
    Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  17. LUSARDI TA, Phillips JI, Wiedrick JT, Harrington CA, et al
    MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  18. DENGLER-CRISH CM, Smith MA, Wilson GN
    Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  19. BEESLEY S, Olcese J, Saunders C, Bienkiewicz EA, et al
    Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  20. NUNOMURA A, Zhu X, Perry G
    Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
    J Alzheimers Dis. 2016;55:73-75.
    PubMed     Text format     Abstract available


    October 2016
  21. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Successful Scene Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  22. LEE M, Guo JP, Kennedy K, McGeer EG, et al
    A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-beta Protein 42 Levels.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  23. MENDIOLA-PRECOMA J, Padilla K, Rodriguez-Cruz A, Berumen LC, et al
    Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  24. DE LA RUBIA ORTI JE, Castillo SS, Benlloch M, Rochina MJ, et al
    Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  25. CUMMINGS J, Scheltens P, McKeith I, Blesa R, et al
    Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  26. CAI Q, Tammineni P
    Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  27. SERINO S, Riva G
    The Proactive Self in Space: How Egocentric and Allocentric Spatial Impairments Contribute to Anosognosia in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  28. CEBERS G, Alexander RC, Haeberlein SB, Han D, et al
    AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  29. ANDERSON M, Xu F, Ou-Yang MH, Davis J, et al
    Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  30. ZHUANG X, Chen Y, Zhuang X, Xing T, et al
    Impaired Center-Surround Suppression in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  31. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1687-1690.
    PubMed     Text format    


  32. LEWCZUK P, Matzen A, Blennow K, Parnetti L, et al
    Cerebrospinal Fluid Abeta42/40 Corresponds Better than Abeta42 to Amyloid PET in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  33. DE LA MONTE SM, Tong M, Schiano I, Didsbury J, et al
    Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  34. CRISPOLTONI L, Stabile AM, Pistilli A, Venturelli M, et al
    Changes in Plasma beta-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  35. TONG Z, Wang W, Luo W, Lv J, et al
    Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  36. ANDREOTTI J, Dierks T, Wahlund LO, Grieder M, et al
    Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  37. MCCLURE R, Ong H, Janve V, Barton S, et al
    Aerosol Delivery of Curcumin Reduced Amyloid-beta Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  38. NOGUCHI-SHINOHARA M, Komatsu J, Samuraki M, Matsunari I, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  39. MARTINS IV, Rivers-Auty J, Allan SM, Lawrence CB, et al
    Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  40. LAITERA T, Paananen J, Helisalmi S, Sarajarvi T, et al
    Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-beta Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  41. DRONSE J, Fliessbach K, Bischof GN, von Reutern B, et al
    In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  42. COSKUN P, Helguera P, Nemati Z, Bohannan RC, et al
    Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  43. SHEN Y, Xia Y, Meng S, Lim NK, et al
    SH2B1 is Involved in the Accumulation of Amyloid-beta42 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  44. HUEY ED, Lee S, Cheran G, Grafman J, et al
    Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  45. ULSTEIN I, Bohmer T
    Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  46. DEKENS DW, Naude PJ, Engelborghs S, Vermeiren Y, et al
    Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  47. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1249.
    PubMed     Text format    



  48. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1253-1257.
    PubMed     Text format    


  49. MCGEER PL, Rogers J, McGeer EG
    Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    J Alzheimers Dis. 2016;54:853-857.
    PubMed     Text format     Abstract available


  50. LIN F, Ren P, Lo RY, Chapman BP, et al
    Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  51. VARMA VR, Watts A
    Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  52. RIVERO-SANTANA A, Ferreira D, Perestelo-Perez L, Westman E, et al
    Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  53. AN H, Choi B, Park KW, Kim DH, et al
    The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  54. MIRANDA LF, Gomes KB, Tito PA, Silveira JN, et al
    Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  55. WANG R, Reddy PH
    Role of Glutamate and NMDA Receptors in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  56. LEGER D, Elbaz M, Dubois A, Rio S, et al
    Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  57. DUCLOS H, de La Sayette V, Bonnet AL, Viard A, et al
    Social Cognition in the Frontal Variant of Alzheimer's Disease: A Case Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  58. JHA SK, Jha NK, Kumar D, Sharma R, et al
    Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  59. KEPP KP
    Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  60. CUCCARO D, De Marco EV, Cittadella R, Cavallaro S, et al
    Copy Number Variants in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  61. XIE B, Liu Z, Jiang L, Liu W, et al
    Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  62. HAFKEMEIJER A, Moller C, Dopper EG, Jiskoot LC, et al
    A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  63. SERRA L, Mancini M, Cercignani M, Di Domenico C, et al
    Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  64. KITAMURA Y, Inden M, Kimoto Y, Takata K, et al
    Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  65. ARNERIC SP, Batrla-Utermann R, Beckett L, Bittner T, et al
    Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  66. DINKINS MB, Wang G, Bieberich E
    Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  67. KIM J, Schweizer TA, Fischer CE, Munoz DG, et al
    The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  68. DARST BF, Koscik RL, Racine AM, Oh JM, et al
    Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-beta Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  69. GUO L, Tian J, Du H
    Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  70. PHILIPPENS IH, Ormel PR, Baarends G, Johansson M, et al
    Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  71. RAHA AA, Henderson JW, Stott SR, Vuono R, et al
    Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  72. BETHEA CL, Reddy AP, Christian FL
    How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  73. ARDEKANI BA, Bermudez E, Mubeen AM, Bachman AH, et al
    Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  74. RODRIGUEZ CRUZ Y, Strehaiano M, Rodriguez Obaya T, Garcia Rodriguez JC, et al
    An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  75. LEWCZUK P, Lelental N, Lachmann I, Holzer M, et al
    Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  76. ZIMETTI F, Caffarra P, Ronda N, Favari E, et al
    Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  77. DAL-PAN A, Dudonne S, Bourassa P, Bourdoulous M, et al
    Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  78. MYUNG W, Lee C, Park JH, Woo SY, et al
    Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  79. DOMINGUEZ-PRIETO M, Velasco A, Vega L, Tabernero A, et al
    Aberrant Co-Localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  80. BRUGGENJURGEN B, Andersohn F, Burkowitz J, Ezzat N, et al
    Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  81. SAINAGHI PP, Bellan M, Lombino F, Alciato F, et al
    Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  82. ROBILLARD JM, Feng TL
    Health Advice in a Digital World: Quality and Content of Online Information about the Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  83. TURRO-GARRIGA O, Garre-Olmo J, Rene-Ramirez R, Calvo-Perxas L, et al
    Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  84. MUSUNURI S, Khoonsari PE, Mikus M, Wetterhall M, et al
    Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  85. TOMBINI M, Sicari M, Pellegrino G, Ursini F, et al
    Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  86. MUELLER KD, Koscik RL, Turkstra LS, Riedeman SK, et al
    Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  87. GOOSSENS J, Laton J, Van Schependom J, Gielen J, et al
    EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  88. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:847-52.
    PubMed     Text format    


  89. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016;54:845.
    PubMed     Text format    


  90. MAGNIN E, Demonet JF, Wallon D, Dumurgier J, et al
    Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  91. RACINE AM, Clark LR, Berman SE, Koscik RL, et al
    Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  92. MUKHAMEDYAROV MA, Rizvanov AA, Yakupov EZ, Zefirov AL, et al
    Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  93. WIJESINGHE P, Shankar SK, Yasha TC, Gorrie C, et al
    Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  94. BRODY M, Liu E, Di J, Lu M, et al
    A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  95. MAZZEO S, Santangelo R, Bernasconi MP, Cecchetti G, et al
    Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  96. BENGOETXEA X, de Cerain AL, Azqueta A, Ramirez MJ, et al
    Purported Interactions of Amyloid-beta and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  97. FARR SA, Sandoval KE, Niehoff ML, Witt KA, et al
    Peripheral Administration of GSK-3beta Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  98. FRIED I
    Brain Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  99. RAJMOHAN R, Reddy PH
    Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  100. YOSHINO Y, Mori T, Yoshida T, Yamazaki K, et al
    Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  101. RENARD D, Gabelle A, Hirtz C, Demattei C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  102. LEVY B, Tsoy E, Gable S
    Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  103. ESTRADA LD, Chamorro D, Yanez MJ, Gonzalez M, et al
    Reduction of Blood Amyloid-beta Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  104. MARESOVA P, Klimova B, Novotny M, Kuca K, et al
    Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe- A Call for a Uniform European Strategy.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  105. RAI N, Kumar R, Desai GR, Venugopalan G, et al
    Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  106. WOLFSGRUBER S, Kleineidam L, Wagner M, Mosch E, et al
    Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  107. TAHERI S, Yu J, Zhu H, Kindy MS, et al
    High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  108. SHANKLE WR, Hara J, Barrentine LW, Curole MV, et al
    CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  109. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:411-5.
    PubMed     Text format    



  110. Mark W. Bondi, PhD, Recipient of 2016 Alzheimer Award.
    J Alzheimers Dis. 2016;54:1-2.
    PubMed     Text format    


  111. SCHARRE DW, Chang SI, Nagaraja HN, Park A, et al
    Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  112. LIMA S, Gago M, Garrett C, Pereira MG, et al
    Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  113. SEPE-MONTI M, Vanacore N, Bartorelli L, Tognetti A, et al
    The Savvy Caregiver Program: A Probe Multicenter Randomized Controlled Pilot Trial in Caregivers of Patients Affected by Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  114. YU Q, Fang D, Swerdlow RH, Yu H, et al
    Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  115. CHAPLEAU M, Aldebert J, Montembeault M, Brambati SM, et al
    Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  116. DE BEAUMONT L, Pelleieux S, Lamarre-Theroux L, Dea D, et al
    Butyrylcholinesterase K and Apolipoprotein E-varepsilon4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  117. MAHESHWARI P, Eslick GD
    Bacterial Infection Increases the Risk of Alzheimer's Disease: An Evidence-Based Assessment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  118. VAN STEENOVEN I, Aarsland D, Weintraub D, Londos E, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
    J Alzheimers Dis. 2016;54:287-95.
    PubMed     Text format     Abstract available


  119. GERTJE EC, Pluta J, Das S, Mancuso L, et al
    Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  120. SELIVANOVA OM, Surin AK, Marchenkov VV, Dzhus UF, et al
    The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-beta Peptide.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  121. CHEN G, Shu H, Chen G, Ward BD, et al
    Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  122. VIJAYAN M, Reddy PH
    Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  123. EL HAJ M, Antoine P
    Death Preparation and Boredom Reduction as Functions of Reminiscence in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  124. CALDERON-GARCIDUENAS L, Avila-Ramirez J, Calderon-Garciduenas A, Gonzalez-Heredia T, et al
    Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  125. HAKOBYAN S, Harding K, Aiyaz M, Hye A, et al
    Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  126. KANG JM, Yeon BK, Cho SJ, Suh YH, et al
    Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  127. VILLARREAL AE, Grajales S, O'Bryant SE, Edwards M, et al
    Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  128. SEO EH, Kim SH, Park SH, Kang SH, et al
    Topographical APOE varepsilon4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  129. HO BL, Kao YH, Chou MC, Yang YH, et al
    Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:351-7.
    PubMed     Text format     Abstract available


  130. WANG H, Wang Y, Hong X, Li S, et al
    Quantitative Proteomics Reveals the Mechanism of Oxygen Treatment on Lenses of Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2016;54:275-86.
    PubMed     Text format     Abstract available


  131. JAAKKIMAINEN RL, Bronskill SE, Tierney MC, Herrmann N, et al
    Identification of Physician-Diagnosed Alzheimer's Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians' Electronic Medical Records.
    J Alzheimers Dis. 2016;54:337-49.
    PubMed     Text format     Abstract available


  132. LIU S, Ong YT, Hilal S, Loke YM, et al
    The Association Between Retinal Neuronal Layer and Brain Structure is Disrupted in Patients with Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  133. BECKELMAN BC, Day S, Zhou X, Donohue M, et al
    Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  134. ROSENBERG PB, Lanctot KL, Herrmann N, Mintzer JE, et al
    Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:373-81.
    PubMed     Text format     Abstract available


  135. SOMERS C, Struyfs H, Goossens J, Niemantsverdriet E, et al
    A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
    J Alzheimers Dis. 2016;54:383-95.
    PubMed     Text format     Abstract available


  136. MARTIRE S, Fuso A, Mosca L, Forte E, et al
    Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    J Alzheimers Dis. 2016;54:307-24.
    PubMed     Text format     Abstract available



  137. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1653-7.
    PubMed     Text format    



  138. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1231-5.
    PubMed     Text format    


  139. ITZHAKI RF
    Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  140. AROSIO B, Casati M, Gussago C, Ferri E, et al
    Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  141. GOLDWASER EL, Acharya NK, Sarkar A, Godsey G, et al
    Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  142. GRINBERG LT, Anghinah R, Nascimento CF, Amaro E, et al
    Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  143. MANDECKA M, Budziszewska M, Barczak A, Peplonska B, et al
    Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  144. ULAMEK-KOZIOL M, Kocki J, Bogucka-Kocka A, Petniak A, et al
    Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  145. HULSEMANN M, Zafiu C, Kuhbach K, Luhmann N, et al
    Biofunctionalized Silica Nanoparticles: Standards in Amyloid-beta Oligomer-Based Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  146. MIDORIKAWA A, Leyton CE, Foxe D, Landin-Romero R, et al
    All Is Not Lost: Positive Behaviors in Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia with Disease Severity.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  147. DURAZZO TC, Korecka M, Trojanowski JQ, Weiner MW, et al
    Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  148. MALPAS CB, Vivash L, Genc S, Saling MM, et al
    A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  149. CHIASSERINI D, Biscetti L, Farotti L, Eusebi P, et al
    Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  150. LOZANO AM, Fosdick L, Chakravarty MM, Leoutsakos JM, et al
    A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  151. VENTURELLI M, Sollima A, Ce E, Limonta E, et al
    Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1631-40.
    PubMed     Text format     Abstract available


  152. JAKOBSEN JE, Johansen MG, Schmidt M, Liu Y, et al
    Expression of the Alzheimer's Disease Mutations AbetaPP695sw and PSEN1M146I in Double-Transgenic Gottingen Minipigs.
    J Alzheimers Dis. 2016;53:1617-30.
    PubMed     Text format     Abstract available


  153. LI X, Jia S, Zhou Z, Hou C, et al
    The Gesture Imitation in Alzheimer's Disease Dementia and Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;53:1577-84.
    PubMed     Text format     Abstract available


  154. ROSSINI PM, Di Iorio R, Granata G, Miraglia F, et al
    From Mild Cognitive Impairment to Alzheimer's Disease: A New Perspective in the "Land" of Human Brain Reactivity and Connectivity.
    J Alzheimers Dis. 2016;53:1389-93.
    PubMed     Text format     Abstract available


  155. ETTCHETO M, Petrov D, Pedros I, Alva N, et al
    Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    J Alzheimers Dis. 2016;54:233-51.
    PubMed     Text format     Abstract available



  156. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:747-51.
    PubMed     Text format    


  157. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:745.
    PubMed     Text format    


  158. PENNINKILAMPI R, Brothers HM, Eslick GD
    Pharmacological Agents Targeting gamma-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  159. DE VOS A, Struyfs H, Jacobs D, Fransen E, et al
    The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  160. BANGEN KJ, Himali JJ, Beiser AS, Nation DA, et al
    Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  161. KANG S, Jeong H, Baek JH, Lee SJ, et al
    PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  162. ADIELE RC, Adiele CA
    Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  163. SALEM H, Rocha NP, Colpo GD, Teixeira AL, et al
    Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  164. DAVID R, Manera V, Fabre R, Pradier C, et al
    Evolution of the Rate of Antidepressant Prescriptions in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  165. IDRIZBEGOVIC E, Hederstierna C, Rosenhall U
    Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  166. ANDERSSON CH, Hansson O, Minthon L, Andreasen N, et al
    A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  167. AMBROSE CT
    The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  168. GROSSI E, Stoccoro A, Tannorella P, Migliore L, et al
    Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  169. BRONNICK K, Breitve MH, Rongve A, Aarsland D, et al
    Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  170. ZIMMERER VC, Wibrow M, Varley RA
    Formulaic Language in People with Probable Alzheimer's Disease: A Frequency-Based Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  171. PIETTO M, Parra MA, Trujillo N, Flores F, et al
    Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  172. BIELLA G, Fusco F, Nardo E, Bernocchi O, et al
    Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-beta Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  173. DENG Y, Wei J, Cheng J, Zhong P, et al
    Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  174. ALLEN HB
    Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-beta with Regard to Potential Treatment and Prevention.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  175. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:363-6.
    PubMed     Text format    


  176. MAKOVAC E, Serra L, Spano B, Giulietti G, et al
    Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:591-604.
    PubMed     Text format     Abstract available


  177. PRETORIUS E, Bester J, Kell DB
    A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  178. MOHSENI HK, Cowan D, Chettle DR, Milic AP, et al
    A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  179. WANG J, Ye F, Cheng X, Zhang X, et al
    The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  180. HAWKINS KM, Sergio LE
    Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  181. LIN CY, Cheng YS, Liao TY, Lin C, et al
    Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-beta Accumulation in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  182. CHOURAKI V, Reitz C, Maury F, Bis JC, et al
    Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  183. VERMEIREN Y, Janssens J, Aerts T, Martin JJ, et al
    Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  184. OLSEN I, Singhrao SK
    Inflammasome Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  185. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  186. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:1515-9.
    PubMed     Text format    


    May 2016
  187. HOFRICHTER J, Krohn M, Schumacher T, Lange C, et al
    Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's beta-Amyloidosis Mouse Models and Aged C57Bl/6 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  188. ALLUE JA, Sarasa L, Izco M, Perez-Grijalba V, et al
    Outstanding Phenotypic Differences in the Profile of Amyloid-beta between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  189. CAMPANARI ML, Navarrete F, Ginsberg SD, Manzanares J, et al
    Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  190. DERMODY N, Wong S, Ahmed R, Piguet O, et al
    Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  191. ARENDASH GW
    Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  192. EUGENIN J, Vecchiola A, Murgas P, Arroyo P, et al
    Expression Pattern of Scavenger Receptors and Amyloid-beta Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  193. OBOSHI Y, Kikuchi M, Terada T, Yoshikawa E, et al
    Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic alpha4beta2 Receptor Availability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  194. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:1151-1155.
    PubMed     Text format    


  195. DEL VALLE E, Navarro A, Martinez-Pinilla E, Torices S, et al
    Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  196. HIRD MA, Egeto P, Fischer CE, Naglie G, et al
    A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  197. TAIPA R, Sousa AL, Melo Pires M, Sousa N, et al
    Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  198. LANDEL V, Annweiler C, Millet P, Morello M, et al
    Vitamin D, Cognition, and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  199. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:775-779.
    PubMed     Text format    


  200. DI MECO A, Pratico D
    MicroRNAs as Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  201. TAJEDDINN W, Persson T, Calvo-Garrido J, Seed Ahmed M, et al
    Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  202. SZALARDY L, Zadori D, Klivenyi P, Vecsei L, et al
    The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  203. KASZA A, Hunya A, Frank Z, Fulop F, et al
    Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  204. FARNSWORTH B, Peuckert C, Zimmermann B, Jazin E, et al
    Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  205. WANG MJ, Yi S, Han JY, Park SY, et al
    Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  206. HAPPICH M, Kirson NY, Desai U, King S, et al
    Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  207. MALISZEWSKA-CYNA E, Xhima K, Aubert I
    A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  208. VERMA N, Ly H, Liu M, Chen J, et al
    Intraneuronal Amylin Deposition Peroxidative Membrane Injury and Increased IL-1beta Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  209. BOLIVAR JC, Saladie DG
    Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  210. TAJEDDINN W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, et al
    Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  211. RUSSU A, Samtani MN, Xu S, Adedokun OJ, et al
    Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016

  212. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:385-9.
    PubMed     Text format    


  213. MARIN-MUNOZ J, Noguera-Perea MF, Gomez-Tortosa E, Lopez-Motos D, et al
    Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  214. EL GAAMOUCH F, Jing P, Xia J, Cai D, et al
    Alzheimer's Disease Risk Genes and Lipid Regulators.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  215. UEKAWA K, Hasegawa Y, Senju S, Nakagata N, et al
    Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  216. YE BS, Lee Y, Kwak K, Park YH, et al
    Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  217. TROJANO L, Gainotti G
    Drawing Disorders in Alzheimer's Disease and Other Forms of Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  218. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  219. HAN P, Shi J
    A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  220. MULLER S, Mychajliw C, Reichert C, Melcher T, et al
    Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  221. CRETIN B, Sellal F, Philippi N, Bousiges O, et al
    Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  222. CLARELLI F, Mascia E, Santangelo R, Mazzeo S, et al
    CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  223. INGBER AP, Hassenstab J, Fagan AM, Benzinger TL, et al
    Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  224. HENSLEY K, Kursula P
    Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  225. BERGER M, Nadler JW, Friedman A, McDonagh DL, et al
    The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  226. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:1291-5.
    PubMed     Text format    


  227. OTA K, Oishi N, Ito K, Fukuyama H, et al
    Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  228. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  229. HOSCHEIDT SM, Starks EJ, Oh JM, Zetterberg H, et al
    Insulin Resistance is Associated with Increased Alzheimer's Disease Pathology and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  230. CONDE-SALA JL, Turro-Garriga O, Portellano-Ortiz C, Vinas-Diez V, et al
    Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  231. WANG W, Lu L, Wu QQ, Jia JP, et al
    Brain Amyloid-beta Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  232. REGO A, Viana SD, Ribeiro CA, Rodrigues-Santos P, et al
    Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  233. XING Y, Tang Y, Zhao L, Wang Q, et al
    Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  234. NILSSON ED, Melander O, Elmstahl S, Lethagen E, et al
    Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  235. TEIPEL S, Grothe MJ
    Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  236. HENNEGES C, Reed C, Chen YF, Dell'Agnello G, et al
    Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  237. WARAGAI M, Adame A, Trinh I, Sekiyama K, et al
    Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  238. ZHAN Y, Ma J, Alexander-Bloch AF, Xu K, et al
    Longitudinal Study of Impaired Intra- and Inter-Network Brain Connectivity in Subjects at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  239. BEHESHTI I, Olya HG, Demirel H
    Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  240. HUANG HC, Zheng BW, Guo Y, Zhao J, et al
    Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  241. JAYNE T, Newman M, Verdile G, Sutherland G, et al
    Evidence for and Against a Pathogenic Role of Reduced gamma-Secretase Activity in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  242. ZHAI Y, Yin S, Zhang D
    Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  243. EBRAHIMIE E, Moussavi-Nik SH, Newman M, Van Der Hoek M, et al
    The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  244. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:929-934.
    PubMed     Text format    


  245. PIAZZA F, Winblad B
    Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  246. VIDAL JS, Hanon O, Funalot B, Brunel N, et al
    Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  247. KUSTER OC, Kosel J, Spohn S, Schurig N, et al
    Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  248. CUCHILLO-IBANEZ I, Balmaceda V, Mata-Balaguer T, Lopez-Font I, et al
    Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  249. HIRNI DI, Kivisaari SL, Krumm S, Monsch AU, et al
    Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  250. CLEMENTS-CORTES A, Ahonen H, Evans M, Freedman M, et al
    Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  251. YANG C, Huang X, Huang X, Mai H, et al
    Aquaporin-4 and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  252. HU Q, Teng W, Li J, Hao F, et al
    Homocysteine and Alzheimer's Disease: Evidence for a Causal Link from Mendelian Randomization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  253. MIN JY, Min KB
    The Folate-Vitamin B12 Interaction, Low Hemoglobin, and the Mortality Risk from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  254. ZHAO QF, Wan Y, Wang HF, Sun FR, et al
    ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-beta Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  255. EL HAJ M, Kapogiannis D, Antoine P
    Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  256. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:631-5.
    PubMed     Text format    


  257. NHO K, Saykin AJ, Nelson PT
    Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  258. SCHUTT T, Helboe L, Ostergaard Pedersen L, Waldemar G, et al
    Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  259. WANG HF, Wan Y, Hao XK, Cao L, et al
    Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  260. HOMMA A, Atarashi H, Kubota N, Nakai K, et al
    Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  261. ITZHAKI RF, Lathe R, Balin BJ, Ball MJ, et al
    Microbes and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format    


  262. YE Q, Bai F, Zhang Z
    Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  263. SPILMAN PR, Corset V, Gorostiza O, Poksay KS, et al
    Netrin-1 Interrupts Amyloid-beta Amplification, Increases sAbetaPPalpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  264. SHANG J, Yamashita T, Zhai Y, Nakano Y, et al
    Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  265. LOPEZ ME, Turrero A, Cuesta P, Lopez-Sanz D, et al
    Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  266. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  267. FEMMINELLA GD, Ninan S, Atkinson R, Fan Z, et al
    Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    J Alzheimers Dis. 2016;51:1275-89.
    PubMed     Text format     Abstract available


  268. YOON B, Yang DW, Hong YJ, Choi SH, et al
    Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  269. TIIHONEN M, Taipale H, Tanskanen A, Tiihonen J, et al
    Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  270. PASQUIER F, Sadowsky C, Holstein A, Leterme GL, et al
    Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    February 2016
  271. REMINGTON R, Bechtel C, Larsen D, Samar A, et al
    Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  272. FLORIAN H, Meier A, Gauthier S, Lipschitz S, et al
    Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  273. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:327-331.
    PubMed     Text format    


  274. PECK K, Girard TA, Russo F, Fiocco AJ, et al
    Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  275. SCHILLING MA
    Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  276. TAN CC, Wan Y, Tan MS, Zhang W, et al
    Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  277. LAVALLEE MM, Gandini D, Rouleau I, Vallet GT, et al
    A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  278. GOMAR JJ, Conejero-Goldberg C, Davies P, Goldberg TE, et al
    Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  279. MASOUD AM, Bihaqi SW, Machan JT, Zawia NH, et al
    Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  280. WONG S, Bertoux M, Savage G, Hodges JR, et al
    Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  281. MONTESANTO A, Crocco P, Anfossi M, Smirne N, et al
    The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-varepsilon4 Carriers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  282. GUILLOT F, Kemppainen S, Lavasseur G, Miettinen PO, et al
    Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  283. ONGALI B, Nicolakakis N, Tong XK, Aboulkassim T, et al
    Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  284. BOUSIGES O, Cretin B, Lavaux T, Philippi N, et al
    Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Abeta42, and Abeta40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  285. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:1257-61.
    PubMed     Text format    


  286. SAKAI K, Senda T, Hata R, Kuroda M, et al
    Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  287. BARTHELEMY NR, Gabelle A, Hirtz C, Fenaille F, et al
    Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  288. CHAI YL, Yeo HK, Wang J, Hilal S, et al
    Apolipoprotein varepsilon4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  289. SANCHEZ-VALLE R, Monte GC, Sala-Llonch R, Bosch B, et al
    White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  290. SUPPA P, Hampel H, Kepp T, Lange C, et al
    Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  291. SINGHRAO SK, Harding A, Chukkapalli S, Olsen I, et al
    Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  292. PLUTA R, Kocki J, Ulamek-Koziol M, Petniak A, et al
    Discrepancy in Expression of beta-Secretase and Amyloid-beta Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  293. CHAU SA, Chung J, Herrmann N, Eizenman M, et al
    Apathy and Attentional Biases in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  294. LYOO CH, Cho H, Choi JY, Hwang MS, et al
    Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  295. LOU G, Zhang Q, Xiao F, Xiang Q, et al
    Intranasal TAT-haFGF Improves Cognition and Amyloid-beta Pathology in an AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  296. SOUTHAM KA, Vincent AJ, Small DH
    Do Microglia Default on Network Maintenance in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  297. DINGOVA D, Fazekas T, Okuliarova P, Strbova J, et al
    Low Plasma Cholinesterase Activities are associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  298. MOON Y, Han SH, Moon WJ
    Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  299. BONET-COSTA V, Herranz-Perez V, Blanco-Gandia M, Mas-Bargues C, et al
    Clearing Amyloid-beta through PPARgamma/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  300. GODEFROY O, Bakchine S, Verny M, Delabrousse-Mayoux JP, et al
    Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  301. FANG D, Zhang Z, Li H, Yu Q, et al
    Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  302. HESSMANN P, Seeberg G, Reese JP, Dams J, et al
    Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  303. SCHUBERT S, Leyton CE, Hodges JR, Piguet O, et al
    Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  304. GRANGER MW, Franko B, Taylor MW, Messier C, et al
    A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  305. ALLISON SL, Fagan AM, Morris JC, Head D, et al
    Spatial Navigation in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  306. CHEN HY, Panegyres PK
    The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  307. WHITE MT, Shaw LM, Xie SX
    Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  308. SERRA L, Cercignani M, Mastropasqua C, Torso M, et al
    Longitudinal Changes in Functional Brain Connectivity Predicts Conversionto Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  309. ASO E, Andres-Benito P, Carmona M, Maldonado R, et al
    Cannabinoid Receptor 2 Participates in Amyloid-beta Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  310. D'ONOFRIO G, Panza F, Sancarlo D, Paris FF, et al
    Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  311. LOUWERSHEIMER E, Keulen MA, Steenwijk MD, Wattjes MP, et al
    Heterogeneous Language Profiles in Patients with Primary Progressive Aphasiadue to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  312. LI WX, Dai SX, Liu JQ, Wang Q, et al
    Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learningand Memory.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  313. WRUCK W, Schroter F, Adjaye J
    Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsiesand iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Revealsan Association with FOXA1 and FOXA2 Gene Regulatory Networks.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  314. KIDA J, Nemoto K, Ikejima C, Bun S, et al
    Impact of Depressive Symptomson Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  315. LACALLE-AURIOLES M, Javier Navas-Sanchez F, Aleman-Gomez Y, Olazaran J, et al
    The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  316. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Speciesin Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  317. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:907-911.
    PubMed     Text format    


    January 2016
  318. BOCCHETTA M, Mega A, Bernardi L, Di Maria E, et al
    Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  319. EUSTACHE P, Nemmi F, Saint-Aubert L, Pariente J, et al
    Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  320. TONG M, Deochand C, Didsbury J, de la Monte SM, et al
    T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  321. MELAH KE, Lu SY, Hoscheidt SM, Alexander AL, et al
    Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  322. LANGLOIS R, Joubert S, Benoit S, Dostie V, et al
    Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease:The Importance of Rehearsal.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  323. ROBILLARD JM
    The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  324. DODICH A, Cerami C, Crespi C, Canessa N, et al
    Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  325. RACINE E, Forlini C, Aspler J, Chandler J, et al
    Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  326. TURRO-GARRIGA O, Garre-Olmo J, Calvo-Perxas L, Rene-Ramirez R, et al
    Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  327. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:617-21.
    PubMed     Text format    


  328. MANOUSOPOULOU A, Saito S, Yamamoto Y, Al-Daghri NM, et al
    Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  329. SMITH R, Wibom M, Olsson T, Hagerstrom D, et al
    Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  330. NAGATA T, Shinagawa S, Nakajima S, Plitman E, et al
    Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  331. WANG HF, Tan L, Cao L, Zhu XC, et al
    Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  332. PASQUINI L, Scherr M, Tahmasian M, Myers NE, et al
    Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  333. GALLUCCI M, Spagnolo P, Arico M, Grossi E, et al
    Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  334. RODRIGUEZ-PERDIGON M, Solas M, Javier Ramirez M
    JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  335. ZHANG Y, Wang S, Phillips P, Yang J, et al
    Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  336. MORIN JP, Ceron-Solano G, Velazquez-Campos G, Pacheco-Lopez G, et al
    Spatial Memory Impairment is Associated with Intraneural Amyloid-beta Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  337. NUNEZ K, Kay J, Krotow A, Tong M, et al
    Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  338. MANSO Y, Comes G, Lopez-Ramos JC, Belfiore M, et al
    Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  339. NIEMANTSVERDRIET E, Goossens J, Struyfs H, Martin JJ, et al
    Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  340. WANG J, Tan L, Yu JT
    Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  341. BABIC LEKO M, Borovecki F, Dejanovic N, Hof PR, et al
    Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  342. SIOTTO M, Simonelli I, Pasqualetti P, Mariani S, et al
    Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  343. BOCCARDI V, Ruggiero C, Patriti A, Marano L, et al
    Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  344. WANG HL, Wang YY, Liu XG, Kuo SH, et al
    Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  345. FERNANDEZ G, Manes F, Politi LE, Orozco D, et al
    Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  346. QIU H, Zhong R, Liu H, Zhang F, et al
    Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AbetaPPswe/PS1DeltaE9 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  347. MAES A, Anthonissen R, Wambacq S, Simons K, et al
    The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  348. KIM HJ, Cha J, Lee JM, Shin JS, et al
    Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  349. KOCH G, Di Lorenzo F, Del Olmo MF, Bonni S, et al
    Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  350. ROHER AE, Maarouf CL, Kokjohn TA
    Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  351. VIJAYARAGHAVAN S, Darreh-Shori T, Rongve A, Berge G, et al
    Association of Butyrylcholinesterase-K Allele and Apolipoprotein E varepsilon4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  352. HUANG F, Shang Y, Luo Y, Wu P, et al
    Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  353. RENARD D, Wacongne A, Ayrignac X, Charif M, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  354. DZIEDZIC T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, et al
    Biochemical and Radiological Markers of Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  355. IBARRIA M, Alegret M, Valero S, Morera A, et al
    Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  356. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:297-300.
    PubMed     Text format    


    December 2015

  357. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:1193-6.
    PubMed     Text format    



  358. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:889-92.
    PubMed     Text format    


  359. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;49:887.
    PubMed     Text format    


  360. BENNETT J, Burns J, Welch P, Bothwell R, et al
    Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  361. DERMODY N, Hornberger M, Piguet O, Hodges JR, et al
    Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  362. HOFFMANN K, Sobol NA, Frederiksen KS, Beyer N, et al
    Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  363. YAMASHITA S, Kiko T, Fujiwara H, Hashimoto M, et al
    Alterations in the Levels of Amyloid-beta, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-beta and These Lipids.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  364. CHAKRABARTI M, McDonald AJ, Will Reed J, Moss MA, et al
    Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  365. WANG S, Zhang Y, Liu G, Phillips P, et al
    Detection of Alzheimer's Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  366. GARDENER SL, Rainey-Smith SR, Martins RN
    Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  367. EZRA A, Rabinovich-Nikitin I, Rabinovich-Toidman P, Solomon B, et al
    Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  368. BARTOLOTTI N, Segura L, Lazarov O
    Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  369. MALISHKEVICH A, Marshall GA, Schultz AP, Sperling RA, et al
    Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  370. WEISSMANN R, Huttenrauch M, Kacprowski T, Bouter Y, et al
    Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  371. STOCKBURGER C, Miano D, Baeumlisberger M, Pallas T, et al
    A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  372. CHANG YL, Yen YS, Chen TF, Yan SH, et al
    Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  373. QUINTANA-HERNANDEZ DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, Pino AS, et al
    Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  374. FISCHER CE, Qian W, Schweizer TA, Millikin CP, et al
    Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  375. STEENLAND K, Goldstein FC, Levey A, Wharton W, et al
    A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  376. GAO L, Cui Z, Shen L, Ji HF, et al
    Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  377. AVONDINO E, Antoine P
    Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  378. MARRA C, Gainotti G, Fadda L, Perri R, et al
    Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  379. SANTOS CY, Lim YY, Wu WC, Machan JT, et al
    Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-beta and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  380. GABELLE A, Gutierrez LA, Dartigues JF, Ritchie K, et al
    Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  381. NOVAK G, Fox N, Clegg S, Nielsen C, et al
    Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  382. LIU J, Zhang X, Yu C, Duan Y, et al
    Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  383. DUKART J, Sambataro F, Bertolino A
    Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  384. SATTLECKER M, Khondoker M, Proitsi P, Williams S, et al
    Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  385. TOSTO G, Monsell SE, Hawes SE, Giuseppe B, et al
    Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  386. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:583-7.
    PubMed     Text format    


  387. BERTOUX M, de Souza Lc LC, O'Callaghan C, Greve A, et al
    Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?
    J Alzheimers Dis. 2015;49:1065-74.
    PubMed     Text format     Abstract available


  388. RHODIUS-MEESTER HF, Koikkalainen J, Mattila J, Teunissen CE, et al
    Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  389. LANGE C, Suppa P, Frings L, Brenner W, et al
    Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  390. STOGMANN E, Moser D, Klug S, Gleiss A, et al
    Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  391. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:267-70.
    PubMed     Text format    


    October 2015
  392. ROSENBERGER AF, Hilhorst R, Coart E, Garcia Barrado L, et al
    Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  393. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:1129-32.
    PubMed     Text format    


  394. DIAZ M, Fabelo N, Casanas-Sanchez V, Marin R, et al
    Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  395. JOHNEN A, Frommeyer J, Modes F, Wiendl H, et al
    Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia based on Apraxia Profiles.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  396. BERGE G, Lauridsen C, Sando SB, Holder D, et al
    Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  397. WU HZ, Ong KL, Seeher K, J Armstrong N, et al
    Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  398. MADHAVAN A, Schwarz CG, Duffy JR, Strand EA, et al
    Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  399. DUBOIS B, Padovani A, Scheltens P, Rossi A, et al
    Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  400. SAARELAINEN L, Taipale H, Koponen M, Tanskanen A, et al
    The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  401. FA M, Zhang H, Staniszewski A, Saeed F, et al
    Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  402. BANERJEE P, Sahoo A, Anand S, Bir A, et al
    The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-beta Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  403. PINNOCK EC, Jovanovic K, Pinto MG, Ferreira E, et al
    LRP/LR Antibody Mediated Rescuing of Amyloid-beta-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  404. KOPPARA A, Wolfsgruber S, Kleineidam L, Schmidtke K, et al
    The Latent Dementia Phenotype delta is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  405. YE BS, Jang EY, Kim SY, Kim EJ, et al
    Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  406. FRASER KC, Meltzer JA, Rudzicz F
    Linguistic Features Identify Alzheimer's Disease in Narrative Speech.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  407. VOYLE N, Keohane A, Newhouse S, Lunnon K, et al
    A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  408. SHAH DJ, Rohlfing F, Anand S, Johnson WE, et al
    Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  409. GARCIA BARRADO L, Coart E, Vanderstichele HM, Burzykowski T, et al
    Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  410. PAN Y, Terpstra E, Wang Y, Qiao F, et al
    Dysregulation and Diagnostic Potential of microRNA in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  411. MINH DO T, Dodacki A, Alata W, Calon F, et al
    Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-beta Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  412. JOUSSAIN P, Bessy M, Fournel A, Ferdenzi C, et al
    Altered Affective Evaluations of Smells in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  413. LEVAULT KR, Tischkau SA, Brewer GJ
    Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  414. ARAB L, Sabbagh MN
    Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?
    J Alzheimers Dis. 2015;48:877.
    PubMed     Text format    



  415. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:871-4.
    PubMed     Text format    


  416. GUO Z, Liu X, Jia X, Hou H, et al
    Regional Coherence Changes in Alzheimer's Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study.
    J Alzheimers Dis. 2015;48:603-11.
    PubMed     Text format     Abstract available


    September 2015
  417. PASTOR P, Moreno F, Clarimon J, Ruiz A, et al
    MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEvarepsilon4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  418. COUTU JP, Goldblatt A, Rosas HD, Salat DH, et al
    White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  419. GAVETT BE, John SE, Gurnani AS, Bussell CA, et al
    The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  420. AGOSTINI S, Mancuso R, Baglio F, Cabinio M, et al
    Lack of Evidence for a Role of HHV-6 in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  421. PIERROT N, Lhommel R, Quenon L, Hanseeuw B, et al
    Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  422. CONEJERO-GOLDBERG C, Hyde TM, Chen S, Herman MM, et al
    Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  423. LIZIO R, Del Percio C, Marzano N, Soricelli A, et al
    Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  424. VALECH N, Mollica MA, Olives J, Tort A, et al
    Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2015;48 Suppl 1:S87-98.
    PubMed     Text format     Abstract available


  425. WHITEHOUSE PJ, George DR
    A Tale of Two Reports: What Recent Publications from the Alzheimer's Association and Institute of Medicine say about the State of the Field.
    J Alzheimers Dis. 2015.
    PubMed     Text format    


  426. SUN X, Ma R, Yao X, Shang X, et al
    Concanavalin Agglutinin Levels are Decreased in Peripheral Blood of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  427. YOON B, Shim YS, Park HK, Park S, et al
    Predictive Factors for Disease Progression in Patients With Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  428. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  429. SPIEGEL J, Pirraglia E, Li Y, Tsui W, et al
    Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  430. KIM HJ, Park KW, Kim TE, Im JY, et al
    Elevation of the Plasma Abeta40/Abeta 42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  431. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015;49:101-10.
    PubMed     Text format     Abstract available


  432. BRYNDIS EINARSDOTTIR A, Hardarson SH, Kristjansdottir JV, Bragason DT, et al
    Retinal Oximetry Imaging in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  433. TRIPLETT JC, Swomley AM, Cai J, Klein JB, et al
    Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  434. LIU H, Qiu H, Xiao Q, Le W, et al
    Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer's Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  435. SPARRE-SORENSEN M, Kristensen G
    Alzheimer's Disease in the Danish Malnutrition Period 1999-2007.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  436. MOON SW, Dinov ID, Kim J, Zamanyan A, et al
    Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  437. ZHENG W, Yao Z, Hu B, Gao X, et al
    Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  438. TORMALEHTO SM, Martikainen JA, Vaatainen ST, Hallikainen IT, et al
    Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  439. CALDERON-GARCIDUENAS L, Mora-Tiscareno A, Sanchez GM, Rodriguez-Diaz J, et al
    A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE varepsilon4 Mexico City Children and Their Parents.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  440. PRICE CC, Tanner JJ, Schmalfuss IM, Brumback B, et al
    Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  441. BIELARCZYK H, Jankowska-Kulawy A, Hofling C, Ronowska A, et al
    AbetaPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  442. MISTRIDIS P, Krumm S, Monsch AU, Berres M, et al
    The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  443. JHA NK, Jha SK, Kumar D, Kejriwal N, et al
    Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  444. GIACCONE G
    The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  445. DIEHL-WIESENECKER E, von Armin CA, Dupuis L, Muller HP, et al
    Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  446. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:557-61.
    PubMed     Text format    


  447. REDDY PH, Blackmon J, Molinar-Lopez V, Ament C, et al
    Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:547-55.
    PubMed     Text format     Abstract available


  448. WOOD PL, Medicherla S, Sheikh N, Terry B, et al
    Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:537-46.
    PubMed     Text format     Abstract available


  449. EL HAJ M, Gely-Nargeot MC, Raffard S
    Destination Memory and Cognitive Theory of Mind in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:529-36.
    PubMed     Text format     Abstract available


  450. SAMURAKI M, Matsunari I, Yoshita M, Shima K, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:517-28.
    PubMed     Text format     Abstract available


  451. SARAJARVI T, Marttinen M, Natunen T, Kauppinen T, et al
    Genetic Variation in delta-Opioid Receptor Associates with Increased beta- and gamma-Secretase Activity in the Late Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:507-16.
    PubMed     Text format     Abstract available


  452. SARLUS H, Eyjolfsdottir H, Eriksdotter M, Oprica M, et al
    Influence of Allergy on Immunoglobulins and Amyloid-beta in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:495-505.
    PubMed     Text format     Abstract available


  453. GAUTHIER S, Rountree S, Finn B, LaPlante B, et al
    Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.
    J Alzheimers Dis. 2015;48:473-81.
    PubMed     Text format     Abstract available


  454. LIAO X, Li G, Wang A, Liu T, et al
    Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;48:463-72.
    PubMed     Text format     Abstract available


  455. LEIFERT WR, Nguyen T, Rembach A, Martins R, et al
    Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    J Alzheimers Dis. 2015;48:443-52.
    PubMed     Text format     Abstract available


  456. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;48:433-41.
    PubMed     Text format     Abstract available


  457. WEISE D, Tiepolt S, Awissus C, Hoffmann KT, et al
    Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2015;48:425-32.
    PubMed     Text format     Abstract available


  458. KEENEY JT, Ibrahimi S, Zhao L
    Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    J Alzheimers Dis. 2015;48:411-24.
    PubMed     Text format     Abstract available


  459. MATSUNAGA S, Kishi T, Annas P, Basun H, et al
    Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;48:403-10.
    PubMed     Text format     Abstract available


  460. SERVELLO A, Fioretti A, Gualdi G, Di Biasi C, et al
    Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1.
    J Alzheimers Dis. 2015;48:395-402.
    PubMed     Text format     Abstract available


  461. REA R, Carotenuto A, Traini E, Fasanaro AM, et al
    Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2015;48:377-83.
    PubMed     Text format     Abstract available


  462. BEYDOUN MA, Beydoun HA, Gamaldo AA, Rostant OS, et al
    Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012.
    J Alzheimers Dis. 2015;48:361-75.
    PubMed     Text format     Abstract available


  463. HARRIS SA, Harris EA
    Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:319-53.
    PubMed     Text format     Abstract available


  464. PISTOLLATO F, Cano SS, Elio I, Vergara MM, et al
    The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:303-18.
    PubMed     Text format     Abstract available


  465. DUBNER L, Wang J, Ho L, Ward L, et al
    Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer's Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  466. POPOVA SN, Pesala S, Alafuzoff I
    To Stage Alzheimer's Disease Related Neurodegeneration Using one Section of Hippocampus.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  467. DI STEFANO F, Epelbaum S, Coley N, Cantet C, et al
    Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  468. DUITS FH, Hernandez-Guillamon M, Montaner J, Goos JD, et al
    Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  469. ERIKSDOTTER M, Vedin I, Falahati F, Freund-Levi Y, et al
    Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  470. YOU SC, Walsh CM, Chiodo LA, Ketelle R, et al
    Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  471. FORAKER J, Millard SP, Leong L, Thomson Z, et al
    The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  472. BILELLO M, Doshi J, Nabavizadeh SA, Toledo JB, et al
    Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  473. MAGISTRI M, Velmeshev D, Makhmutova M, Faghihi MA, et al
    Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-beta Homeostasis, and Deregulated Expression of Long Noncoding RNAs.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  474. KUBO M, Kishi T, Matsunaga S, Iwata N, et al
    Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  475. HONG HS, Maezawa I, Petrlova J, Zhao XY, et al
    Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-beta (Abeta) Oligomer and AbetaPP and Protects Neurons from Abeta-Induced Toxicity.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  476. MEIER S, Bell M, Lyons DN, Ingram A, et al
    Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  477. GRAMUNT N, Buschke H, Sanchez-Benavides G, Lipton RB, et al
    Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  478. MENENDEZ-GONZALEZ M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrion O, et al
    Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  479. MATSUZONO K, Sato K, Kono S, Hishikawa N, et al
    Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    August 2015

  480. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:287-91.
    PubMed     Text format    


  481. MATSUZONO K, Hishikawa N, Yamashita T, Ohta Y, et al
    Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study).
    J Alzheimers Dis. 2015;48:279-86.
    PubMed     Text format     Abstract available


  482. ANDERKOVA L, Eliasova I, Marecek R, Janousova E, et al
    Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation.
    J Alzheimers Dis. 2015;48:251-60.
    PubMed     Text format     Abstract available


  483. HEISKANEN J, Hartikainen S, Roine RP, Tolppanen AM, et al
    30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:241-9.
    PubMed     Text format     Abstract available


  484. BRUEGGEN K, Dyrba M, Barkhof F, Hausner L, et al
    Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    J Alzheimers Dis. 2015;48:197-204.
    PubMed     Text format     Abstract available


  485. SCHMIDT C, Gerlach N, Schmitz M, Thom T, et al
    Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:189-96.
    PubMed     Text format     Abstract available


  486. LI QX, Villemagne VL, Doecke JD, Rembach A, et al
    Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    J Alzheimers Dis. 2015;48:175-87.
    PubMed     Text format     Abstract available


  487. PAPUC E, Kurys-Denis E, Krupski W, Tatara M, et al
    Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
    J Alzheimers Dis. 2015;48:115-21.
    PubMed     Text format     Abstract available


  488. ZHANG XF, Zhao YF, Zhu SW, Huang WJ, et al
    CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:89-104.
    PubMed     Text format     Abstract available


  489. SNIR JA, Suchy M, Lawrence KS, Hudson RH, et al
    Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:73-87.
    PubMed     Text format     Abstract available


  490. SOLLVANDER S, Ekholm-Pettersson F, Brundin RM, Westman G, et al
    Increased Number of Plasma B Cells Producing Autoantibodies Against Abeta42 Protofibrils in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:63-72.
    PubMed     Text format     Abstract available


  491. SIARKOS KT, Katirtzoglou EA, Politis AM
    A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:15-34.
    PubMed     Text format     Abstract available


  492. WESSON ASHFORD J, Mahoney L, Burkett T
    A Role for Complementary and Integrative Medicine in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2015;48:13-4.
    PubMed     Text format     Abstract available


  493. KHALSA DS
    Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
    J Alzheimers Dis. 2015;48:1-12.
    PubMed     Text format     Abstract available


  494. SPALLETTA G, Long JD, Robinson RG, Trequattrini A, et al
    Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  495. ABERG D, Johansson P, Isgaard J, Wallin A, et al
    Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  496. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1079-84.
    PubMed     Text format    


  497. TRAVASSOS M, Santana I, Baldeiras I, Tsolaki M, et al
    Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-beta Levels in Patients with Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:1069-78.
    PubMed     Text format     Abstract available


  498. ZHAN Y, Chen K, Wu X, Zhang D, et al
    Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.
    J Alzheimers Dis. 2015;47:1057-67.
    PubMed     Text format     Abstract available


  499. LIU K, Chojnacki JE, Wade EE, Saathoff JM, et al
    Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1021-33.
    PubMed     Text format     Abstract available


  500. GLEASON CE, Fischer BL, Dowling NM, Setchell KD, et al
    Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1009-19.
    PubMed     Text format     Abstract available


  501. WEILER M, Agosta F, Canu E, Copetti M, et al
    Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    J Alzheimers Dis. 2015;47:995-1007.
    PubMed     Text format     Abstract available


  502. MENDEZ MF, Paholpak P, Lin A, Zhang JY, et al
    Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:985-93.
    PubMed     Text format     Abstract available


  503. QUIROZ YT, Willment KC, Castrillon G, Muniz M, et al
    Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:955-64.
    PubMed     Text format     Abstract available


  504. FU Y, Zhao D, Pan B, Wang J, et al
    Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:915-26.
    PubMed     Text format     Abstract available


  505. LI G, Xiong K, Korff A, Pan C, et al
    Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Abeta42 and Tau.
    J Alzheimers Dis. 2015;47:883-7.
    PubMed     Text format     Abstract available


  506. CATANIA M, Di Fede G, Tonoli E, Benussi L, et al
    Mirror Image of the Amyloid-beta Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:877-81.
    PubMed     Text format     Abstract available


  507. ALONSO R, Pisa D, Rabano A, Rodal I, et al
    Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA.
    J Alzheimers Dis. 2015;47:873-6.
    PubMed     Text format     Abstract available


  508. NOVAIS F, Starkstein S
    Phenomenology of Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:845-55.
    PubMed     Text format     Abstract available


  509. BANIK A, Brown RE, Bamburg J, Lahiri DK, et al
    Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1.
    J Alzheimers Dis. 2015;47:815-43.
    PubMed     Text format     Abstract available



  510. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:787-91.
    PubMed     Text format    


  511. VALOTASSIOU V, Papatriantafyllou J, Sifakis N, Tzavara C, et al
    Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:773-85.
    PubMed     Text format     Abstract available


  512. BRADLEY-WHITMAN MA, Abner E, Lynn BC, Lovell MA, et al
    A Novel Plasma Based Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:761-71.
    PubMed     Text format     Abstract available


  513. CHIAM JT, Lunnon K, Voyle N, Proitsi P, et al
    No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:741-50.
    PubMed     Text format     Abstract available


  514. NORDBERG A, Kadir A, Andreasen N, Almkvist O, et al
    Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
    J Alzheimers Dis. 2015;47:691-704.
    PubMed     Text format     Abstract available


  515. JENSEN-DAHM C, Waldemar G, Staehelin Jensen T, Malmqvist L, et al
    Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:681-9.
    PubMed     Text format     Abstract available


  516. TANG X, Holland D, Dale AM, Miller MI, et al
    APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
    J Alzheimers Dis. 2015;47:645-60.
    PubMed     Text format     Abstract available


  517. CHO SJ, Yun SM, Lee DH, Jo C, et al
    Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:639-43.
    PubMed     Text format     Abstract available


  518. VIRK SA, Eslick GD
    Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer's Disease Cases than in Controls: A Series of Meta-Analyses.
    J Alzheimers Dis. 2015;47:629-38.
    PubMed     Text format     Abstract available


  519. NAKANO Y, Matsuzono K, Yamashita T, Ohta Y, et al
    Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).
    J Alzheimers Dis. 2015;47:609-17.
    PubMed     Text format     Abstract available


  520. WANG ZX, Tan L, Wang HF, Ma J, et al
    Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
    J Alzheimers Dis. 2015;47:565-81.
    PubMed     Text format     Abstract available


  521. TIEPOLT S, Patt M, Hoffmann KT, Schroeter ML, et al
    Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
    J Alzheimers Dis. 2015;47:539-43.
    PubMed     Text format     Abstract available


  522. FLORIS G, Di Stefano F, Cherchi MV, Costa G, et al
    Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?
    J Alzheimers Dis. 2015;47:535-8.
    PubMed     Text format     Abstract available


    July 2015

  523. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:531-4.
    PubMed     Text format    


  524. GIIL LM, Kristoffersen EK, Vedeler CA, Aarsland D, et al
    Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:523-9.
    PubMed     Text format     Abstract available


  525. YIN RH, Tan L, Liu Y, Wang WY, et al
    Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:495-507.
    PubMed     Text format     Abstract available


  526. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    J Alzheimers Dis. 2015;47:487-93.
    PubMed     Text format     Abstract available


  527. LEON C, Pin S, Kreft-Jais C, Arwidson P, et al
    Perceptions of Alzheimer's Disease in the French Population: Evolutions between 2008 and 2013 and Associated Factors in 2013.
    J Alzheimers Dis. 2015;47:467-78.
    PubMed     Text format     Abstract available


  528. RANGASAMY SB, Corbett GT, Roy A, Modi KK, et al
    Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:385-402.
    PubMed     Text format     Abstract available


  529. PIMENTEL LS, Allard S, Do Carmo S, Weinreb O, et al
    The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:373-83.
    PubMed     Text format     Abstract available


  530. HARTL D, Gu W, Mayhaus M, Pichler S, et al
    Amyloid-beta Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015;47:365-72.
    PubMed     Text format     Abstract available


  531. STEEL AJ, Eslick GD
    Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;47:351-64.
    PubMed     Text format     Abstract available


  532. ROMAN GC
    MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:323-7.
    PubMed     Text format     Abstract available


  533. LISTA S, O'Bryant SE, Blennow K, Dubois B, et al
    Biomarkers in Sporadic and Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:291-317.
    PubMed     Text format     Abstract available


  534. KINCSES ZT, Kiraly A, Vereb D, Vecsei L, et al
    Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.
    J Alzheimers Dis. 2015;47:277-90.
    PubMed     Text format     Abstract available



  535. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:273-6.
    PubMed     Text format    



  536. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    J Alzheimers Dis. 2015;47:271.
    PubMed     Text format    


  537. VAN HARTEN AC, Mulders J, Scheltens P, van der Flier WM, et al
    Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:243-52.
    PubMed     Text format     Abstract available


  538. EDMONDS EC, Delano-Wood L, Galasko DR, Salmon DP, et al
    Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:231-42.
    PubMed     Text format     Abstract available


  539. LIU-SEIFERT H, Siemers E, Price K, Han B, et al
    Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:205-14.
    PubMed     Text format     Abstract available


  540. NAKAMAGOE K, Fujimiya S, Koganezawa T, Kadono K, et al
    Vestibular Function Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:185-96.
    PubMed     Text format     Abstract available


  541. BUSSE S, Steiner J, Alter J, Dobrowolny H, et al
    Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:177-84.
    PubMed     Text format     Abstract available


  542. WANG Q, Jia J, Qin W, Wu L, et al
    A Novel AbetaPP M722K Mutation Affects Amyloid-beta Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals.
    J Alzheimers Dis. 2015;47:157-65.
    PubMed     Text format     Abstract available


  543. WESSON ASHFORD J
    Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions.
    J Alzheimers Dis. 2015;47:149-56.
    PubMed     Text format     Abstract available


  544. WARING JF, Tang Q, Robieson WZ, King DP, et al
    APOE-varepsilon4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:137-48.
    PubMed     Text format     Abstract available


  545. JOHNSON LA, Gamboa A, Vintimilla R, Cheatwood AJ, et al
    Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    J Alzheimers Dis. 2015;47:129-36.
    PubMed     Text format     Abstract available


  546. RUDNITSKAYA EA, Muraleva NA, Maksimova KY, Kiseleva E, et al
    Melatonin Attenuates Memory Impairment, Amyloid-beta Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:103-16.
    PubMed     Text format     Abstract available


  547. ATWOOD CS, Bowen RL
    A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015;47:33-47.
    PubMed     Text format     Abstract available


  548. GROBLEWSKA M, Muszynski P, Wojtulewska-Supron A, Kulczynska-Przybik A, et al
    The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:17-32.
    PubMed     Text format     Abstract available


  549. MOOSAVI B, Mousavi B, Macreadie IG
    Yeast Model of Amyloid-beta and Tau Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:9-16.
    PubMed     Text format     Abstract available


    June 2015

  550. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1129-33.
    PubMed     Text format    


  551. GUSTAFSON DR, Clare Morris M, Scarmeas N, Shah RC, et al
    New Perspectives on Alzheimer's Disease and Nutrition.
    J Alzheimers Dis. 2015;46:1111-27.
    PubMed     Text format     Abstract available


  552. JONGBLOED W, van Dijk KD, Mulder SD, van de Berg WD, et al
    Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1103-10.
    PubMed     Text format     Abstract available


  553. BURNHAM SC, Raghavan N, Wilson W, Baker D, et al
    Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
    J Alzheimers Dis. 2015;46:1079-89.
    PubMed     Text format     Abstract available


  554. WANG H, Tan L, Wang HF, Liu Y, et al
    Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;46:1049-70.
    PubMed     Text format     Abstract available


  555. ASSELINEAU D, Benlhassan K, Arosio B, Mari D, et al
    Interleukin-10 Production in Response to Amyloid-beta Differs between Slow and Fast Decliners in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:837-42.
    PubMed     Text format     Abstract available


  556. KHAN TK, Alkon DL
    Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.
    J Alzheimers Dis. 2015;46:817-36.
    PubMed     Text format     Abstract available



  557. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:813-6.
    PubMed     Text format    


  558. TEDONE E, Arosio B, Colombo F, Ferri E, et al
    Leukocyte Telomere Length in Alzheimer's Disease Patients with a Different Rate of Progression.
    J Alzheimers Dis. 2015;46:761-9.
    PubMed     Text format     Abstract available


  559. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).
    J Alzheimers Dis. 2015;46:687-93.
    PubMed     Text format     Abstract available


  560. MOODLEY KK, Perani D, Minati L, Anthony Della Rosa P, et al
    Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    J Alzheimers Dis. 2015;46:639-53.
    PubMed     Text format     Abstract available


    May 2015

  561. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:549-52.
    PubMed     Text format    


  562. WANG C, Tan L, Wang HF, Yu WJ, et al
    Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:491-5.
    PubMed     Text format     Abstract available


  563. TERNI B, Ferrer I
    Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.
    J Alzheimers Dis. 2015;46:461-9.
    PubMed     Text format     Abstract available



  564. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:285-7.
    PubMed     Text format    


    April 2015
  565. WURTMAN RJ
    How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-beta and Less Phosphatidylcholine.
    J Alzheimers Dis. 2015;46:983-7.
    PubMed     Text format     Abstract available


  566. ZHANG WI, Antonios G, Rabano A, Bayer TA, et al
    Super-Resolution Microscopy of Cerebrospinal Fluid Biomarkers as a Tool for Alzheimer's Disease Diagnostics.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  567. PISCOPO P, Tosto G, Belli C, Talarico G, et al
    SORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  568. YEO HG, Lee Y, Jeon CY, Jeong KJ, et al
    Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  569. COART E, Barrado LG, Duits FH, Scheltens P, et al
    Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  570. OLESON S, Murphy C
    Olfactory Dysfunction in ApoE epsilon4/4 Homozygotes with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  571. HANSEN HH, Fabricius K, Barkholt P, Niehoff ML, et al
    The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  572. BOCCIA M, Acierno M, Piccardi L
    Neuroanatomy of Alzheimer's Disease and Late-Life Depression: A Coordinate-Based Meta-Analysis of MRI Studies.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  573. KONG D, Giovanello KS, Wang Y, Lin W, et al
    Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  574. SHEN L, Ji HF
    Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  575. BREWER GJ
    Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  576. ELLIS B, Hye A, Snowden SG
    Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  577. PUSSWALD G, Lehrner J, Hagmann M, Dal-Bianco P, et al
    Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer's Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  578. VILLA C, Ferini-Strambi L, Combi R
    The Synergistic Relationship between Alzheimer's Disease and Sleep Disorders: An Update.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  579. AVAN A, Hoogenraad TU
    Zinc and Copper in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    March 2015
  580. ALTAMURA C, Ventriglia M, Martini MG, Montesano D, et al
    Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  581. O'DAY DH, Eshak K, Myre MA
    Calmodulin Binding Proteins and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  582. SAVAGE MJ, Holder DJ, Wu G, Kaplow J, et al
    Soluble BACE-1 Activity and sAbetaPPbeta Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  583. PORTBURY SD, Adlard PA
    Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer's Disease: Common Pathologies Potentiated by Altered Zinc Homeostasis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  584. BALDUCCI C, Paladini A, Micotti E, Tolomeo D, et al
    The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  585. DE LA TORRE JC
    Do We Try Mending Humpty Dumpty or Prevent His Fall? An Alzheimer's Disease Dilemma.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  586. KORTVELYESSY P, Gukasjan A, Sweeny-Reed C, Heinze HJ, et al
    Progranulin and Amyloid-beta Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  587. SEAMAN JB, Terhorst L, Gentry A, Hunsaker A, et al
    Psychometric Properties of a Decisional Capacity Screening Tool for Individuals Contemplating Participation in Alzheimer's Disease Research.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  588. GAGO MF, Fernandes V, Ferreira J, Yelshyna D, et al
    Role of the Visual and Auditory Systems in Postural Stability in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  589. VELAYUDHAN L, Gasper A, Pritchard M, Baillon S, et al
    Pattern of Smell Identification Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  590. WOJSIAT J, Prandelli C, Laskowska-Kaszub K, Martin-Requero A, et al
    Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  591. BUDOLFSON K, Malek-Ahmadi M, Belden CM, Powell J, et al
    Neuropsychological Correlates of the Alzheimer's Questionnaire.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  592. NIJHOLT DA, Ijsselstijn L, van der Weiden MM, Zheng PP, et al
    Pregnancy Zone Protein is Increased in the Alzheimer's Disease Brain and Associates with Senile Plaques.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  593. MIGLIACCIO R, Agosta F, Possin KL, Canu E, et al
    Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  594. JANG H, Kim JH, Choi SH, Lee Y, et al
    Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  595. DI MARCO LY, Farkas E, Martin C, Venneri A, et al
    Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  596. ZEIFMAN LE, Eddy WF, Lopez OL, Kuller LH, et al
    Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  597. DINKINS MB, Dasgupta S, Wang G, Zhu G, et al
    The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  598. THEOFILAS P, Dunlop S, Heinsen H, Grinberg LT, et al
    Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  599. BACCHETTI T, Vignini A, Giulietti A, Nanetti L, et al
    Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  600. BIK-MULTANOWSKI M, Pietrzyk JJ, Midro A
    MTRNR2L12: A Candidate Blood Marker of Early Alzheimer's Disease-Like Dementia in Adults with Down Syndrome.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  601. BHATTACHARYA S, Maelicke A, Montag D
    Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  602. BREGMAN N, Regev K, Moore O, Giladi N, et al
    A Simple Tool to Reach Populations at Risk for Developing Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  603. LI G, Kim C, Kim J, Yoon H, et al
    Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-beta Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  604. LE PAGE A, Bourgade K, Lamoureux J, Frost E, et al
    NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  605. RICE AC, Ladd AC, Bennett Jr JP
    Postmortem Alzheimer's Disease Hippocampi Show Oxidative Phosphorylation Gene Expression Opposite that of Isolated Pyramidal Neurons.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  606. BOULEAU S, Tricoire H
    Drosophila Models of Alzheimer's Disease: Advances, Limits, and Perspectives.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  607. KOWOLL ME, Degen C, Gladis S, Schroder J, et al
    Neuropsychological Profiles and Verbal Abilities in Lifelong Bilinguals with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  608. VENTRIGLIA M, Brewer GJ, Simonelli I, Mariani S, et al
    Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  609. CAMPBELL SN, Zhang C, Roe AD, Lee N, et al
    Impact of CRFR1 Ablation on Amyloid-beta Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  610. WISSE LE, Reijmer YD, Ter Telgte A, Kuijf HJ, et al
    Hippocampal Disconnection in Early Alzheimer's Disease: A 7 Tesla MRI Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  611. LEE D, Kim WC, Charidimou A, Song M, et al
    A Bird's-Eye View of Alzheimer's Disease Research: Reflecting Different Perspectives of Indexers, Authors, or Citers in Mapping the Field.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  612. RICHARD BC, Kurdakova A, Baches S, Bayer TA, et al
    Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  613. DONOVAN NJ, Hsu DC, Dagley AS, Schultz AP, et al
    Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  614. WANG Y, Wang Y, Sui Y, Yu H, et al
    The Combination of Aricept with a Traditional Chinese Medicine Formula, Smart Soup, May Be a Novel Way to Treat Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  615. QIN W, Jia X, Wang F, Zuo X, et al
    Elevated Plasma Angiogenesis Factors in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  616. PERSICHILLI S, Gervasoni J, Di Napoli A, Fuso A, et al
    Plasma Thiols Levels in Alzheimer's Disease Mice under Diet-Induced Hyperhomocysteinemia: Effect of S-Adenosylmethionine and Superoxide-Dismutase Aupplementation.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  617. BOUVIER DS, Murai KK
    Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  618. OLAZARAN J, Gil-de-Gomez L, Rodriguez-Martin A, Valenti-Soler M, et al
    A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  619. WRIGHT JW, Harding JW
    The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  620. DI PAOLA M, Phillips O, Orfei MD, Piras F, et al
    Corpus Callosum Structure is Topographically Correlated with the Early Course of Cognition and Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  621. CASAMENTI F, Grossi C, Rigacci S, Pantano D, et al
    Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  622. WHITWELL JL, Kantarci K, Weigand SD, Lundt ES, et al
    Microbleeds in Atypical Presentations of Alzheimer's Disease: A Comparison to Dementia of the Alzheimer's Type.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  623. DARST BF, Koscik RL, Hermann BP, La Rue A, et al
    Heritability of Cognitive Traits Among Siblings with a Parental History of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  624. LEUZY A, Carter SF, Chiotis K, Almkvist O, et al
    Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  625. KHONDOKER M, Newhouse S, Westman E, Muehlboeck JS, et al
    Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  626. WANG X, Lopez O, Sweet RA, Becker JT, et al
    Genetic Determinants of Survival in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  627. ZHANG C, Kuo CC, Moghadam SH, Monte L, et al
    Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer's Disease Transgenic Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  628. BROMMELHOFF JA, Sultzer DL
    Brain Structure and Function Related to Depression in Alzheimer's Disease: Contributions from Neuroimaging Research.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  629. BURATTI L, Balestrini S, Altamura C, Viticchi G, et al
    Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  630. PERRONE L, Grant WB
    Observational and Ecological Studies of Dietary Advanced Glycation End Products in National Diets and Alzheimer's Disease Incidence and Prevalence.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  631. ELAHI S, Bachman AH, Lee SH, Sidtis JJ, et al
    Corpus Callosum Atrophy Rate in Mild Cognitive Impairment and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  632. VASAVADA MM, Wang J, Eslinger PJ, Gill DJ, et al
    Olfactory Cortex Degeneration in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  633. BERISHA V, Wang S, LaCross A, Liss J, et al
    Tracking Discourse Complexity Preceding Alzheimer's Disease Diagnosis: A Case Study Comparing the Press Conferences of Presidents Ronald Reagan and George Herbert Walker Bush.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  634. HULL J, Patel V, El Hindy M, Lee C, et al
    Regional Increase in the Expression of the BCAT Proteins in Alzheimer's Disease Brain: Implications in Glutamate Toxicity.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  635. LEE DY, Moon J, Lee ST, Jung KH, et al
    Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  636. WANG X, Wang J, He Y, Li H, et al
    Apolipoprotein E epsilon4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  637. YANG H, Guan H, Yang M, Liu Z, et al
    Upregulation of Mitochondrial Ferritin by Proinflammatory Cytokines: Implications for a Role in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  638. MATSUZONO K, Hishikawa N, Ohta Y, Yamashita T, et al
    Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  639. INZELBERG R, Massarwa M, Schechtman E, Strugatsky R, et al
    Estimating the Risk for Conversion from Mild Cognitive Impairment to Alzheimer's Disease in an Elderly Arab Community.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  640. REMBACH A, Stingo FC, Peterson C, Vannucci M, et al
    Bayesian Graphical Network Analyses Reveal Complex Biological Interactions Specific to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  641. PAN C, Korff A, Galasko D, Ginghina C, et al
    Diagnostic Values of Cerebrospinal Fluid T-Tau and Abeta42 using Meso Scale Discovery Assays for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  642. MORENO-GRAU S, Barneda B, Carriba P, Marin J, et al
    Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  643. MEEKER KD, Meabon JS, Cook DG
    Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  644. MIRANDA LF, Gomes KB, Silveira JN, Pianetti GA, et al
    Predictive Factors of Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer's Disease and Mixed Dementia: A One-Year Naturalistic Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  645. MOYSE E, Bastin C, Salmon E, Bredart S, et al
    Impairment of Age Estimation from Faces in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  646. PISTONO A, Jucla M, Barbeau EJ, Saint-Aubert L, et al
    Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  647. AGOSTINHO P, Pliassova A, Oliveira CR, Cunha RA, et al
    Localization and Trafficking of Amyloid-beta Protein Precursor and Secretases: Impact on Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  648. ZHANG H, Liu J, Sun S, Pchitskaya E, et al
    Calcium Signaling, Excitability, and Synaptic Plasticity Defects in Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  649. VOROBYOV V, Kaptsov V, Gordon R, Makarova E, et al
    Neuroprotective Effects of Hydrated Fullerene C60: Cortical and Hippocampal EEG Interplay in an Amyloid-Infused Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  650. REMINGTON R, Bechtel C, Larsen D, Samar A, et al
    A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  651. WILLIAMS MA, Haughton D, Stevenson M, Craig D, et al
    Plasma Complement factor H in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  652. CRETIN B, Di Bitonto L, Blanc F, Magnin E, et al
    Left Temporal Lobe Epilepsy Revealing Left Posterior Cortical Atrophy Due to Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  653. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:337-9.
    PubMed     Text format    



  654. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:699-700.
    PubMed     Text format    



  655. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:1093-5.
    PubMed     Text format    



  656. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;43:1451-3.
    PubMed     Text format    



  657. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:339-41.
    PubMed     Text format    



  658. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:721-3.
    PubMed     Text format    



  659. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:1035-7.
    PubMed     Text format    



  660. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;44:1375-7.
    PubMed     Text format    


  661. ZHAN X, Jickling GC, Ander BP, Stamova B, et al
    Myelin Basic Protein Associates with AbetaPP, Abeta1-42, and Amyloid Plaques in Cortex of Alzheimer's Disease Brain.
    J Alzheimers Dis. 2015;44:1213-29.
    PubMed     Text format     Abstract available



  662. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;45:321-4.
    PubMed     Text format    



  663. Upcoming meetings related to Alzheimer's diseasew.
    J Alzheimers Dis. 2015;45:675-7.
    PubMed     Text format    


  664. LATTANZI S, Luzzi S, Provinciali L, Silvestrini M, et al
    Blood pressure variability in Alzheimer's disease and frontotemporal dementia: the effect on the rate of cognitive decline.
    J Alzheimers Dis. 2015;45:387-94.
    PubMed     Text format     Abstract available



  665. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;45:981-4.
    PubMed     Text format    



  666. Upcoming meetings related to Alzheimer's disease.
    J Alzheimers Dis. 2015;45:1271-3.
    PubMed     Text format    


  667. SHAKESPEARE TJ, Yong KX, Foxe D, Hodges J, et al
    Pronounced impairment of everyday skills and self-care in posterior cortical atrophy.
    J Alzheimers Dis. 2015;43:381-4.
    PubMed     Text format     Abstract available


  668. MADERNA E, Cattaneo C, Cacciatore F, Catania M, et al
    Divergent cognitive status with the same Braak stage of neurofibrillary pathology: does the pattern of amyloid-beta deposits make the difference?
    J Alzheimers Dis. 2015;43:375-9.
    PubMed     Text format     Abstract available


  669. TUCKER S, Moller C, Tegerstedt K, Lord A, et al
    The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    J Alzheimers Dis. 2015;43:575-88.
    PubMed     Text format     Abstract available


  670. SANTANGELO R, Coppi E, Ferrari L, Bernasconi MP, et al
    Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
    J Alzheimers Dis. 2015;43:1429-40.
    PubMed     Text format     Abstract available


  671. HAGHIGHI M, Smith A, Morgan D, Small B, et al
    Identifying cost-effective predictive rules of amyloid-beta level by integrating neuropsychological tests and plasma-based markers.
    J Alzheimers Dis. 2015;43:1261-70.
    PubMed     Text format     Abstract available


  672. ASO E, Sanchez-Pla A, Vegas-Lozano E, Maldonado R, et al
    Cannabis-based medicine reduces multiple pathological processes in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;43:977-91.
    PubMed     Text format     Abstract available


  673. GIFFORD KA, Liu D, Damon SM, Chapman WG 4th, et al
    Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.
    J Alzheimers Dis. 2015;44:309-18.
    PubMed     Text format     Abstract available


  674. KAWADA H, Blessing K, Kiyota T, Woolman T, et al
    Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-beta metal dyshomeostasis.
    J Alzheimers Dis. 2015;44:297-307.
    PubMed     Text format     Abstract available


  675. JOCHEMSEN HM, van der Flier WM, Ashby EL, Teunissen CE, et al
    Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.
    J Alzheimers Dis. 2015;44:153-62.
    PubMed     Text format     Abstract available


  676. ECKERSTROM C, Olsson E, Klasson N, Berge J, et al
    Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
    J Alzheimers Dis. 2015;44:205-14.
    PubMed     Text format     Abstract available


  677. SIECZKOWSKI E, Milenkovic I, Venkataramani V, Giera R, et al
    I716F AbetaPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-beta and alpha-synucleinopathy with Lewy bodies.
    J Alzheimers Dis. 2015;44:103-14.
    PubMed     Text format     Abstract available


  678. ROBB E, Perez K, Hung LW, Masters CL, et al
    High order W02-reactive stable oligomers of amyloid-beta are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-beta monomer.
    J Alzheimers Dis. 2015;44:69-78.
    PubMed     Text format     Abstract available


  679. MERRIL CR, Ghanbari HA
    Two hundred issues later: the dream comes true.
    J Alzheimers Dis. 2015;44:727-8.
    PubMed     Text format    


  680. PERRY G
    Two hundred treasured issues!
    J Alzheimers Dis. 2015;44:725.
    PubMed     Text format    


  681. BARRETT JP, Minogue AM, Jones RS, Ribeiro C, et al
    Bone marrow-derived macrophages from AbetaPP/PS1 mice are sensitized to the effects of inflammatory stimuli.
    J Alzheimers Dis. 2015;44:949-62.
    PubMed     Text format     Abstract available


  682. KIM HJ, Im K, Kwon H, Lee JM, et al
    Effects of amyloid and small vessel disease on white matter network disruption.
    J Alzheimers Dis. 2015;44:963-75.
    PubMed     Text format     Abstract available


  683. PUIG KL, Lutz BM, Urquhart SA, Rebel AA, et al
    Overexpression of mutant amyloid-beta protein precursor and presenilin 1 modulates enteric nervous system.
    J Alzheimers Dis. 2015;44:1263-78.
    PubMed     Text format     Abstract available


  684. ORDONEZ-GUTIERREZ L, Anton M, Wandosell F
    Peripheral amyloid levels present gender differences associated with aging in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;44:1063-8.
    PubMed     Text format     Abstract available


  685. KOAL T, Klavins K, Seppi D, Kemmler G, et al
    Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels.
    J Alzheimers Dis. 2015;44:1193-201.
    PubMed     Text format     Abstract available


  686. LUNA-MUNOZ J, Perry G, Guevara J
    Raul Mena: 1953-2014.
    J Alzheimers Dis. 2015;45:325-7.
    PubMed     Text format    


  687. ITO K, Fukuyama H, Senda M, Ishii K, et al
    Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
    J Alzheimers Dis. 2015;45:543-52.
    PubMed     Text format     Abstract available


  688. MEISSNER JN, Bouter Y, Bayer TA
    Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta3-42.
    J Alzheimers Dis. 2015;45:471-82.
    PubMed     Text format     Abstract available


  689. STRUYFS H, Van Broeck B, Timmers M, Fransen E, et al
    Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-beta Isoforms for Early and Differential Dementia Diagnosis.
    J Alzheimers Dis. 2015;45:813-22.
    PubMed     Text format     Abstract available


  690. PENG L, Yu Y, Liu J, Li S, et al
    The chemerin receptor CMKLR1 is a functional receptor for amyloid-beta peptide.
    J Alzheimers Dis. 2015;43:227-42.
    PubMed     Text format     Abstract available


  691. UHM KO, Kim MJ, Kawaguchi M, Akatsu H, et al
    ATBF1 is a novel amyloid-beta protein precursor (AbetaPP) binding protein that affects AbetaPP expression.
    J Alzheimers Dis. 2015;43:243-57.
    PubMed     Text format     Abstract available


  692. LI JG, Pratico D
    High levels of homocysteine results in cerebral amyloid angiopathy in mice.
    J Alzheimers Dis. 2015;43:29-35.
    PubMed     Text format     Abstract available


  693. GOZES I, Yeheskel A, Pasmanik-Chor M
    Activity-dependent neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer.
    J Alzheimers Dis. 2015;45:57-73.
    PubMed     Text format     Abstract available


  694. SUN Y, Bresell A, Rantalainen M, Hoglund K, et al
    An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Abeta1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2015;45:1061-76.
    PubMed     Text format     Abstract available


  695. NIEMANTSVERDRIET E, Feyen BF, Le Bastard N, Martin JJ, et al
    Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up.
    J Alzheimers Dis. 2015;45:1039-43.
    PubMed     Text format     Abstract available


    December 2014
  696. WISCHIK CM, Staff RT, Wischik DJ, Bentham P, et al
    Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  697. SILVERI MC, Ferrante I, Brita AC, Rossi P, et al
    "The Memory of Beauty" Survives Alzheimer's Disease (but Cannot Help Memory).
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  698. LACHNO DR, Evert BA, Maloney K, Willis BA, et al
    Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-beta Peptides in Cerebrospinal Fluid Specimens from Alzheimer's Disease Studies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  699. ARMAND-UGON M, Aso E, Moreno J, Riera-Codina M, et al
    Memory Improvement in the AbetaPP/PS1 Mouse Model of Familial Alzheimer's Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  700. JONGBLOED W, Bruggink KA, Kester MI, Visser P, et al
    Amyloid-beta Oligomers Relate to Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  701. PAMPHLETT R, Kum Jew S
    Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-beta and Tau Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  702. MUNIZ R, Serra CM, Reisberg B, Rojo JM, et al
    Cognitive-Motor Intervention in Alzheimer's Disease: Long-Term Results from the Maria Wolff Trial.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  703. NISHIOKA C, Poh C, Sun S
    Diffusion Tensor Imaging Reveals Visual Pathway Damage in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  704. LOVESTONE S, Boada M, Dubois B, Hull M, et al
    A Phase II Trial of Tideglusib in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  705. WILKINS HM, Carl SM, Weber SG, Ramanujan SA, et al
    Mitochondrial Lysates Induce Inflammation and Alzheimer's Disease-Relevant Changes in Microglial and Neuronal Cells.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  706. BONCORAGLIO GB, Piazza F, Savoiardo M, Farina L, et al
    Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Abeta Autoantibodies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  707. BUN S, Ikejima C, Kida J, Yoshimura A, et al
    A Combination of Supplements May Reduce the Risk of Alzheimer's Disease in Elderly Japanese with Normal Cognition.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  708. SUSANTO TA, Pua EP, Zhou J
    Cognition, Brain Atrophy, and Cerebrospinal Fluid Biomarkers Changes from Preclinical to Dementia Stage of Alzheimer's Disease and the Influence of Apolipoprotein E.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  709. SUN Y, Rong X, Lu W, Peng Y, et al
    Translational Study of Alzheimer's Disease (AD) Biomarkers from Brain Tissues in AbetaPP/PS1 Mice and Serum of AD Patients.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  710. MONACELLI F, Borghi R, Cammarata S, Nencioni A, et al
    Amnestic Mild Cognitive Impairment and Conversion to Alzheimer's Disease: Insulin Resistance and Glycoxidation as Early Biomarker Clusters.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  711. SENA CM, Pereira AM, Carvalho C, Fernandes R, et al
    Type 2 Diabetes Aggravates Alzheimer's Disease-Associated Vascular Alterations of the Aorta in Mice.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    November 2014
  712. JINGAMI N, Uemura K, Noto R, Asada M, et al
    Idiopathic Normal Pressure Hydrocephalus has a Different Cerebrospinal Fluid Biomarker Profile from Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  713. CHEUNG CY, Ong YT, Hilal S, Ikram MK, et al
    Retinal Ganglion Cell Analysis Using High-Definition Optical Coherence Tomography in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  714. OLAH Z, Kalman J, Toth ME, Zvara A, et al
    Proteomic Analysis of Cerebrospinal Fluid in Alzheimer's Disease: Wanted Dead or Alive.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  715. KETTUNEN P, Larsson S, Holmgren S, Olsson S, et al
    Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  716. NOLAN JM, Loskutova E, Howard A, Mulcahy R, et al
    The Impact of Supplemental Macular Carotenoids in Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  717. SALZA R, Oudart JB, Ramont L, Maquart FX, et al
    Endostatin Level in Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  718. RYAN NS, Lashley T, Revesz T, Dantu K, et al
    Spontaneous ARIA (Amyloid-Related Imaging Abnormalities) and Cerebral Amyloid Angiopathy Related Inflammation in Presenilin 1-Associated Familial Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  719. HUTTENRAUCH M, Baches S, Gerth J, Bayer TA, et al
    Neprilysin Deficiency Alters the Neuropathological and Behavioral Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  720. BULATI M, Buffa S, Martorana A, Gervasi F, et al
    Double Negative (IgG+IgD-CD27-) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer's Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  721. LANE RM, Darreh-Shori T
    Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  722. WILLIAMS PT
    Lower Risk of Alzheimer's Disease Mortality with Exercise, Statin, and Fruit Intake.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  723. WATT AD, Perez KA, Ang CS, O'Donnell P, et al
    Peripheral alpha-Defensins 1 and 2 are Elevated in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  724. SEEBURGER JL, Holder DJ, Combrinck M, Joachim C, et al
    Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  725. KIM YJ, Cho H, Kim YJ, Ki CS, et al
    Apolipoprotein E4 Affects Topographical Changes in Hippocampal and Cortical Atrophy in Alzheimer's Disease Dementia: A Five-Year Longitudinal Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  726. CHAUDHRY M, Wang X, Bamne MN, Hasnain S, et al
    Genetic Variation in Imprinted Genes is Associated with Risk of Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  727. WUCHERER D, Eichler T, Kilimann I, Hertel J, et al
    Antidementia Drug Treatment in People Screened Positive for Dementia in Primary Care.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  728. DI DOMENICO F, Pupo G, Mancuso C, Barone E, et al
    Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1/BVR-A System: Insights for Transition to Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  729. INGENBLEEK Y, Bernstein LH
    Downsizing of Lean Body Mass is a Key Determinant of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  730. JANG JW, Park SY, Park YH, Baek MJ, et al
    A Comprehensive Visual Rating Scale of Brain Magnetic Resonance Imagine: Application in Elderly Subjects with Alzheimer's Disease, Mild Cognitive Impairment, and Normal Cognition.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  731. HUMPHRIES CE, Kohli MA, Nathanson L, Whitehead P, et al
    Integrated Whole Transcriptome and DNA Methylation Analysis Identifies Gene Networks Specific to Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  732. KHAN TK, Alkon DL
    Peripheral Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  733. DAUPHINOT V, Delphin-Combe F, Mouchoux C, Dorey A, et al
    Risk Factors of Caregiver Burden Among Patients with Alzheimer's Disease or Related Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  734. HASCUP KN, Hascup ER
    Altered Neurotransmission Prior to Cognitive Decline in AbetaPP/PS1 Mice, a Model of Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  735. HAWKINS KM, Goyal AI, Sergio LE
    Diffusion Tensor Imaging Correlates of Cognitive-Motor Decline in Normal Aging and Increased Alzheimer's Disease Risk.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  736. CLAXTON A, Baker LD, Hanson A, Trittschuh EH, et al
    Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    October 2014
  737. MORBELLI S, Brugnolo A, Bossert I, Buschiazzo A, et al
    Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  738. FOLEY AM, Ammar ZM, Lee RH, Mitchell CS, et al
    Systematic Review of the Relationship between Amyloid-beta Levels and Measures of Transgenic Mouse Cognitive Deficit in Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  739. AL-KHATEEB E, Althaher A, Al-Khateeb M, Al-Musawi H, et al
    Relation between Uric Acid and Alzheimer's Disease in Elderly Jordanians.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  740. GRAHAM SF, Nasarauddin MB, Carey M, McGuinness B, et al
    Quantitative Measurement of [Na+] and [K+] in Postmortem Human Brain Tissue Indicates Disturbances in Subjects with Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  741. MARCHANT NL, Howard RJ
    Cognitive Debt and Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  742. ACQUAAH-MENSAH GK, Agu N, Khan T, Gardner A, et al
    A Regulatory Role for the Insulin- and BDNF-Linked RORA in the Hippocampus: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


  743. RANGARAJU S, Gearing M, Jin LW, Levey A, et al
    Potassium Channel Kv1.3 Is Highly Expressed by Microglia in Human Alzheimer's Disease.
    J Alzheimers Dis. 2014.
    PubMed     Text format     Abstract available


    January 2014
  744. MINERS JS, Jones R, Love S
    Differential changes in Abeta42 and Abeta40 with age.
    J Alzheimers Dis. 2014;40:727-35.
    PubMed     Text format     Abstract available


  745. QIANG M, Xiao R, Su T, Wu BB, et al
    A novel mechanism for endogenous formaldehyde elevation in SAMP8 mouse.
    J Alzheimers Dis. 2014;40:1039-53.
    PubMed     Text format     Abstract available


  746. TROUSSIERE AC, Wallon D, Mouton-Liger F, Yatimi R, et al
    Who needs cerebrospinal biomarkers? A national survey in clinical practice.
    J Alzheimers Dis. 2014;40:857-61.
    PubMed     Text format     Abstract available


  747. BRINKLEY WR, Perry G
    Lester (Skip) Binder (1949-2013): in the beginning was tau.
    J Alzheimers Dis. 2014;40 Suppl 1:S5.
    PubMed     Text format    


  748. MEDINA M, Avila J
    Is tau a prion-like protein?
    J Alzheimers Dis. 2014;40 Suppl 1:S1-3.
    PubMed     Text format    


  749. ANDO K, Kabova A, Stygelbout V, Leroy K, et al
    Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    J Alzheimers Dis. 2014;40 Suppl 1:S135-45.
    PubMed     Text format     Abstract available


  750. CONGDON EE, Krishnaswamy S, Sigurdsson EM
    Harnessing the immune system for treatment and detection of tau pathology.
    J Alzheimers Dis. 2014;40 Suppl 1:S113-21.
    PubMed     Text format     Abstract available


  751. ROSEN AC, Ashford JW, Perry G
    Ethics review as a catalyst for progress.
    J Alzheimers Dis. 2014;40:233-5.
    PubMed     Text format     Abstract available


  752. SAYAS CL, Avila J
    Crosstalk between axonal classical microtubule-associated proteins and end binding proteins during axon extension: possible implications in neurodegeneration.
    J Alzheimers Dis. 2014;40 Suppl 1:S17-22.
    PubMed     Text format     Abstract available


  753. AVILA J, Simon D, Diaz-Hernandez M, Pintor J, et al
    Sources of extracellular tau and its signaling.
    J Alzheimers Dis. 2014;40 Suppl 1:S7-S15.
    PubMed     Text format     Abstract available


  754. SCHMAND B, Rienstra A, Tamminga H, Richard E, et al
    Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
    J Alzheimers Dis. 2014;40:409-18.
    PubMed     Text format     Abstract available


  755. VAN DER FLIER WM, Pijnenburg YA, Prins N, Lemstra AW, et al
    Optimizing patient care and research: the Amsterdam Dementia Cohort.
    J Alzheimers Dis. 2014;41:313-27.
    PubMed     Text format     Abstract available


  756. HARRIS CJ, Voss K, Murchison C, Ralle M, et al
    Oral zinc reduces amyloid burden in Tg2576 mice.
    J Alzheimers Dis. 2014;41:179-92.
    PubMed     Text format     Abstract available


  757. MOON M, Cha MY, Mook-Jung I
    Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    J Alzheimers Dis. 2014;41:233-41.
    PubMed     Text format     Abstract available


  758. VECCHIO F, Miraglia F, Marra C, Quaranta D, et al
    Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data.
    J Alzheimers Dis. 2014;41:113-27.
    PubMed     Text format     Abstract available


  759. FITZ NF, Castranio EL, Carter AY, Kodali R, et al
    Improvement of memory deficits and amyloid-beta clearance in aged APP23 mice treated with a combination of anti-amyloid-beta antibody and LXR agonist.
    J Alzheimers Dis. 2014;41:535-49.
    PubMed     Text format     Abstract available


  760. COSKUNER O, Murray IV
    Adenosine triphosphate (ATP) reduces amyloid-beta protein misfolding in vitro.
    J Alzheimers Dis. 2014;41:561-74.
    PubMed     Text format     Abstract available


  761. KORECKA M, Waligorska T, Figurski M, Toledo JB, et al
    Qualification of a surrogate matrix-based absolute quantification method for amyloid-beta(4)(2) in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.
    J Alzheimers Dis. 2014;41:441-51.
    PubMed     Text format     Abstract available


  762. MIGNARDOT JB, Beauchet O, Annweiler C, Cornu C, et al
    Postural sway, falls, and cognitive status: a cross-sectional study among older adults.
    J Alzheimers Dis. 2014;41:431-9.
    PubMed     Text format     Abstract available


  763. RAMI L, Mollica MA, Garcia-Sanchez C, Saldana J, et al
    The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study.
    J Alzheimers Dis. 2014;41:453-66.
    PubMed     Text format     Abstract available


  764. FROESTL W, Muhs A, Pfeifer A
    Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
    J Alzheimers Dis. 2014;41:961-1019.
    PubMed     Text format     Abstract available


  765. FU Y, Rusznak Z, Kwok JB, Kim WS, et al
    Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAbetaPPSwInd-J20 mouse.
    J Alzheimers Dis. 2014;41:1177-92.
    PubMed     Text format     Abstract available


  766. VANGAVARAGU JR, Valasani KR, Fang D, Williams TD, et al
    Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    J Alzheimers Dis. 2014;42:333-44.
    PubMed     Text format     Abstract available


  767. DE BRUIJN RF, Janssen JA, Brugts MP, van Duijn CM, et al
    Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
    J Alzheimers Dis. 2014;42:137-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: